Agomelatine
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Agomelatine and local guidelines before prescribing.
Antidepressant
Mechanism
Melatonin agonist and 5-HT2C antagonist.
Uses
Major depression.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Nausea, headache, raised transaminases.
Interactions
Fluvoxamine and ciprofloxacin raise levels.
Contraindications and cautions
Hepatic impairment
Monitoring
LFT
Pregnancy and breastfeeding
Avoid
Renal and hepatic impairment
Contraindicated in hepatic impairment
Overdose and reversal
Supportive
Special advice
LFT at baseline, 3, 6, 12 and 24 weeks.
More from the textbook: uses, cautions and other points
- Others - vortioxetine, agomelatine, trazodone, bupropion (smoking) | Vortioxetine - fewer sexual side effects; agomelatine - LFT monitoring; trazodone - sedating.
Psychiatry: Mood disorders - Liver disease | Avoid or reduce drugs with heavy liver metabolism; benzodiazepines can precipitate hepatic encephalopathy - use short-acting (lorazepam, oxazepam) at low doses; avoid valproate, duloxetine, agomelatine and naltrexone in severe disease; sertraline or citalopram at low doses.
Psychiatry: Personality, eating and neurodevelopmental disorders
Where it is discussed in the book
- Psychiatry: Mood disorders (1 mention)
- Psychiatry: Personality, eating and neurodevelopmental disorders (1 mention)